Ablynx is a Belgian biopharmaceutical company engaged in the development of Nanobodies®, proprietary therapeutic proteins based on single-domain antibody fragments. Today, the Company has approximately 45 proprietary and partnered programmes in development in various therapeutic areas including inflammation, haematology, immuno-oncology, oncology and respiratory disease.
mediAVentures was involved in the production of a guidance video which is used by HCPs in the drug administration process.
We liked this cooperation because it goes a little outside the typical scope of work, being a biotech company and being involved in the clinical/pre-market stage now instead of the typical educational/training or marketing context. But most of all because of the dynamics and stimulating interactions with the professional client team.
